your favorite gene search
powered by ingenuity
Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides News and InformationSt. Quentin Fallavier, FR - 1er octobre, 2010 Payer Moins, Achetez Plus!
24 €* de produits en plus grâce à Internet... Sigma-Aldrich vous offre les frais de traitement pour toute commande passée sur notre site www.sigma-aldrich.com. Facilitez-vous l'accès à la commande en ligne en utilisant notre nouvelle fonctionnalité “Instant Ordering” *Depuis le 1er octobre 2010, les frais de traitement des commandes fax & courrier sont de 24€. Les conditions commerciales négociées restent inchangées jusqu'à renouvellement des accords. Read MoreSt. Louis, MO - January 31, 2012 Sigma-Aldrich Completes Acquisition of BioReliance
Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced it has completed its acquisition of BioReliance Holdings, Inc., a leading provider of global biopharmaceutical testing services, from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments. Read MoreSt. Louis, MO - January 9, 2012 Sigma-Aldrich Extends Laboratory Chemicals Contract with Honeywell
Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today it has signed a five-year contract extension with Honeywell for the manufacture and supply of Riedel-de Haën® high purity solvents, Karl Fischer reagents and other laboratory chemicals produced at Honeywell's Seelze, Germany, manufacturing site. The contract extends an existing supply agreement, in place since 1999, through March 31, 2019. Read MoreSt. Louis, MO - January 9, 2012 Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced it has signed an agreement to acquire BioReliance Holdings, Inc., a leading provider of global biopharmaceutical testing services, from Avista Capital Partners for $350 million in cash. The acquisition is subject to customary closing conditions, including regulatory clearance, and is expected to close in the first quarter of 2012. Read More view all press releasesL'Information Locale
Number of Products Available from Sigma-Aldrich |